WOSD
VRTX icon

WFA of San Diego’s Vertex Pharmaceuticals VRTX Stock Holding History

WFA of San Diego’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2
Closed -$893 – 369
2026
Q1 		$893 Hold
2
– – ﹤0.01% 383
2025
Q4 		$907 Hold
2
– – ﹤0.01% 388
2025
Q3 		$783 Hold
2
– – ﹤0.01% 407
2025
Q2 		$890 Buy
+2
New +$922 ﹤0.01% 415
2024
Q3 		$931 Hold
2
– – ﹤0.01% 390
2024
Q2 		$938 Buy
+2
New +$868 ﹤0.01% 388
2023
Q3 		$696 Hold
2
– – ﹤0.01% 372
2023
Q2 		$704 Buy
+2
New +$674 ﹤0.01% 363
2022
Q3 		– Sell
-7
Closed -$2K – 389
2022
Q2 		$2K Buy
+7
New +$1.87K ﹤0.01% 361

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

WFA of San Diego's VRTX Position: Q2 2026 in Review

WFA of San Diego sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 2 shares — an estimated $893 sold.

WFA of San Diego first reported a position in VRTX in Q2 2022 and held it in 9 quarters. The position peaked at $2K in Q2 2022. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • WFA of San Diego reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • WFA of San Diego sold 2 Vertex Pharmaceuticals shares in Q2 2026, an estimated $893.
  • WFA of San Diego first reported a position in Vertex Pharmaceuticals in Q2 2022 and held it in 9 quarters.
  • WFA of San Diego's Vertex Pharmaceuticals position peaked at $2K in Q2 2022.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on WFA of San Diego's 13F filing for Q2 2026, filed 14 Aug 2026.